TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Why rare disease patients deserve government care

Patients with rare genetic diseases should be considered “heroes” because they have received a mutation that statistically should occur in a population.

Arief Budi Witarto, Venty Muliana Sari Soeroso and Prihati Pujowaskito (The Jakarta Post)
Premium
Bogor, West Java
Sat, March 2, 2024

Share This Article

Change Size

Why rare disease patients deserve government care Rare talent: Children living with rare disorders perform a Betawi traditional dance at a shopping center in Bekasi, West Java, on Feb. 29, 2024. The event was held by Indonesia Rare Disorders (IRD) to commemorate World Rare Disease Day. (Antara/Fakhri Hermansyah)

A

s we commemorated World Rare Disease Day on Thursday, we were reminded that rare diseases are an opportunity for a nation to show its support for social justice and national defense. We should not consider rare diseases a burden or even a curse.

Rare diseases are illnesses where the number of patients is small, in the realm of one in 2,000 people. In comparison, TB disease affects five in 2,000 people, according to Health Ministry data from 2022. This scarcity has several consequences that require serious attention.

The first is the difficulty of diagnosis, as specialist doctors (mostly pediatricians) are not used to dealing with rare diseases, and medical education tends not to teach these diseases thoroughly, so general practitioners at community health centers often misdiagnose them. The duration of diagnosis can reach 20 years, according to CNN Indonesia.

Second, the cost of treatment is very expensive because drug companies are reluctant to produce the required medicines en masse, given the low demand. In the case of Mucopolysaccharidosis (MPS) type 2, orphan drugs, a term for medications used only for a specific rare disease, will cost a patient Rp 6 billion (US$382,247) a year. In Indonesia, drugs for rare diseases are generally not covered by universal health insurance (BPJS).

Rare diseases are not infectious illnesses caused by pathogens but genetic diseases that are carried from birth. Therefore, cases are generally discovered by pediatricians.

Some genetic mutations are inherited, and interestingly, some are new or de novo. In the process of cell division after the embryo is formed, DNA is copied or replicated for one cell to two cells, which is carried out by the DNA polymerase enzyme.

Viewpoint

Every Thursday

Whether you're looking to broaden your horizons or stay informed on the latest developments, "Viewpoint" is the perfect source for anyone seeking to engage with the issues that matter most.

By registering, you agree with The Jakarta Post's

Thank You

for signing up our newsletter!

Please check your email for your newsletter subscription.

View More Newsletter

This enzyme has an accuracy limit of 1 per 100,000 DNA bases, or 120,000 errors per cell as the amount of DNA in human cells is around 6 billion (Pray, 2008). Fortunately, cells have a correction mechanism called DNA repair which can reduce the probability of errors up to 400 times or to 300 errors per cell (Kunkel, 1996).

to Read Full Story

  • Unlimited access to our web and app content
  • e-Post daily digital newspaper
  • No advertisements, no interruptions
  • Privileged access to our events and programs
  • Subscription to our newsletters
or

Purchase access to this article for

We accept

TJP - Visa
TJP - Mastercard
TJP - GoPay

Redirecting you to payment page

Pay per article

Why rare disease patients deserve government care

Rp 29,000 / article

1
Create your free account
By proceeding, you consent to the revised Terms of Use, and Privacy Policy.
Already have an account?

2
  • Palmerat Barat No. 142-143
  • Central Jakarta
  • DKI Jakarta
  • Indonesia
  • 10270
  • +6283816779933
2
Total Rp 29,000

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.